Ensoma
Clinical trials sponsored by Ensoma, explained in plain language.
-
One-Time infusion aims to fix faulty immune cells
Disease control Recruiting nowThis early-stage study is testing a new one-time gene therapy called EN-374 for people with X-linked chronic granulomatous disease (X-CGD), a rare disorder where the immune system can't fight off serious infections. The main goals are to see if the treatment is safe and if it can…
Phase: PHASE1, PHASE2 • Sponsor: Ensoma • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Scientists map immune defenses in rare disease patients
Knowledge-focused Recruiting nowThis study aims to learn more about the immune system in people with Chronic Granulomatous Disease (CGD), a rare genetic condition that weakens the body's ability to fight infections. Researchers will collect blood samples from about 60 adults and children with CGD to measure the…
Sponsor: Ensoma • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC